These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29990481)

  • 21. Catalytic activity and stereoselectivity of engineered phosphotriesterases towards structurally different nerve agents in vitro.
    Köhler A; Escher B; Job L; Koller M; Thiermann H; Skerra A; Worek F
    Arch Toxicol; 2021 Aug; 95(8):2815-2823. PubMed ID: 34160649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Translating the Concept of Bispecific Antibodies to Engineering Heterodimeric Phosphotriesterases with Broad Organophosphate Substrate Recognition.
    Escher B; Köhler A; Job L; Worek F; Skerra A
    Biochemistry; 2020 Nov; 59(45):4395-4406. PubMed ID: 33146522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Thermophilic Bacterial Esterase for Scavenging Nerve Agents: A Kinetic, Biophysical and Structural Study.
    Bzdrenga J; Trenet E; Chantegreil F; Bernal K; Nachon F; Brazzolotto X
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33513869
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detoxification of organophosphate nerve agents by bacterial phosphotriesterase.
    Ghanem E; Raushel FM
    Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):459-70. PubMed ID: 15982683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatic Decontamination of G-Type, V-Type and Novichok Nerve Agents.
    Jacquet P; Rémy B; Bross RPT; van Grol M; Gaucher F; Chabrière E; de Koning MC; Daudé D
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Organophosphate detoxification by membrane-engineered red blood cells.
    Smith PN; Mao L; Sinha K; Russell AJ
    Acta Biomater; 2021 Apr; 124():270-281. PubMed ID: 33529769
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organophosphorus Nerve Agents: Types, Toxicity, and Treatments.
    Mukherjee S; Gupta RD
    J Toxicol; 2020; 2020():3007984. PubMed ID: 33029136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimization of Cholinesterase-Based Catalytic Bioscavengers Against Organophosphorus Agents.
    Lushchekina SV; Schopfer LM; Grigorenko BL; Nemukhin AV; Varfolomeev SD; Lockridge O; Masson P
    Front Pharmacol; 2018; 9():211. PubMed ID: 29593539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stoichiometric and catalytic scavengers as protection against nerve agent toxicity: a mini review.
    Lenz DE; Yeung D; Smith JR; Sweeney RE; Lumley LA; Cerasoli DM
    Toxicology; 2007 Apr; 233(1-3):31-9. PubMed ID: 17188793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human paraoxonase: a promising approach for pre-treatment and therapy of organophosphorus poisoning.
    Rochu D; Chabrière E; Masson P
    Toxicology; 2007 Apr; 233(1-3):47-59. PubMed ID: 17007987
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SAR study to find optimal cholinesterase reactivator against organophosphorous nerve agents and pesticides.
    Gorecki L; Korabecny J; Musilek K; Malinak D; Nepovimova E; Dolezal R; Jun D; Soukup O; Kuca K
    Arch Toxicol; 2016 Dec; 90(12):2831-2859. PubMed ID: 27582056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress in acetylcholinesterase reactivators and in the treatment of organophosphorus intoxication: a patent review (2006-2016).
    Gorecki L; Korabecny J; Musilek K; Nepovimova E; Malinak D; Kucera T; Dolezal R; Jun D; Soukup O; Kuca K
    Expert Opin Ther Pat; 2017 Sep; 27(9):971-985. PubMed ID: 28569609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of the rePON1 mutant IIG1 to prevent cyclosarin toxicity in vivo and to detoxify structurally different nerve agents in vitro.
    Worek F; Seeger T; Goldsmith M; Ashani Y; Leader H; Sussman JS; Tawfik D; Thiermann H; Wille T
    Arch Toxicol; 2014 Jun; 88(6):1257-66. PubMed ID: 24477626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functionalized cyclodextrins bearing an alpha nucleophile--a promising way to degrade nerve agents.
    Estour F; Letort S; Müller S; Kalakuntla RK; Le Provost R; Wille T; Reiter G; Worek F; Lafont O; Gouhier G
    Chem Biol Interact; 2013 Mar; 203(1):202-7. PubMed ID: 23123247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enzymes hydrolyzing organophosphates as potential catalytic scavengers against organophosphate poisoning.
    Masson P; Josse D; Lockridge O; Viguié N; Taupin C; Buhler C
    J Physiol Paris; 1998; 92(5-6):357-62. PubMed ID: 9789837
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Precision cut lung slices as test system for candidate therapeutics in organophosphate poisoning.
    Herbert J; Thiermann H; Worek F; Wille T
    Toxicology; 2017 Aug; 389():94-100. PubMed ID: 28743514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers.
    Pang Z; Hu CM; Fang RH; Luk BT; Gao W; Wang F; Chuluun E; Angsantikul P; Thamphiwatana S; Lu W; Jiang X; Zhang L
    ACS Nano; 2015 Jun; 9(6):6450-8. PubMed ID: 26053868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive evaluation of novel oximes in creation of butyrylcholinesterase-based nerve agent bioscavengers.
    Katalinić M; Maček Hrvat N; Baumann K; Morasi Piperčić S; Makarić S; Tomić S; Jović O; Hrenar T; Miličević A; Jelić D; Žunec S; Primožič I; Kovarik Z
    Toxicol Appl Pharmacol; 2016 Nov; 310():195-204. PubMed ID: 27654152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acetylcholinesterase-Fc Fusion Protein (AChE-Fc): A Novel Potential Organophosphate Bioscavenger with Extended Plasma Half-Life.
    Noy-Porat T; Cohen O; Ehrlich S; Epstein E; Alcalay R; Mazor O
    Bioconjug Chem; 2015 Aug; 26(8):1753-8. PubMed ID: 26121420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enzyme Nanoreactor for
    Pashirova T; Shaihutdinova Z; Mansurova M; Kazakova R; Shambazova D; Bogdanov A; Tatarinov D; Daudé D; Jacquet P; Chabrière E; Masson P
    ACS Appl Mater Interfaces; 2022 May; 14(17):19241-19252. PubMed ID: 35440137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.